Adverum Biotechnologies Inc (NASDAQ:ADVM) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Patrick Machado Other companies: Alumis Inc. (Independent Board Member · Since at least Jun 27, 2024); Xenon Pharmaceuticals Inc. (Director · Since at least Nov 5, 2020); Arcus Biosciences, Inc. (Board Member · Since at least Dec 10, 2019); Turnstone Biologics Corp. (Director · Jul 20, 2023 – Jul 20, 2023 · Past); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Roivant Sciences Ltd. (Director · Oct 1, 2021 – Oct 1, 2021 · Past); Principia Biopharma Inc (Director · Jun 11, 2019 – Sep 28, 2020 · Past); Turning Point Therapeutics Inc (Director · May 13, 2019 – Aug 17, 2022 · Past); Endocyte Inc (Director · Feb 27, 2018 – Dec 21, 2018 · Past); Sio Gene Therapies Inc (Director · Jul 17, 2017 – Jul 17, 2017 · Past); Rocket Pharmaceuticals, Inc. (Director · Aug 17, 2016 – Jun 20, 2017 · Past); Scynexis, Inc. (Director · Sep 24, 2015 – Jan 2, 2019 · Past); Chimerix Inc (Director · Jun 20, 2014 – Jun 9, 2023 · Past); Medivation Inc (Director · Jun 5, 2007 – Sep 28, 2016 · Past) | Director · Since at least Mar 14, 2017 |
| Athena Countouriotis Other companies: BioMarin Pharmaceutical Inc. (Director · Since at least Dec 27, 2023); Passage Bio, Inc. (Chief Executive Officer and Chairperson of the board of directors of Avenzo Therapeutics · Since at least Feb 27, 2020); Iovance Biotherapeutics, Inc. (Director · Since at least Jun 10, 2019); Turning Point Therapeutics Inc (President & CEO, Director · Apr 16, 2019 – Aug 17, 2022 · Past); Cardiff Oncology, Inc. (Director · Sep 14, 2017 – Jun 20, 2019 · Past); Halozyme Therapeutics, Inc. (SVP and Chief Medical Officer · Jan 5, 2015 – Feb 22, 2017 · Past); Ambit Biosciences Corp (Chief Medical Officer · May 15, 2013 – Nov 10, 2014 · Past) | SVP, Chief Medical Officer · Jun 19, 2017 – Feb 15, 2018 · Past |
| Rekha Hemrajani Other companies: LB Pharmaceuticals Inc (Director · Since at least Sep 10, 2025); BioAge Labs, Inc. (Independent Director · Since at least Apr 17, 2024); MaxCyte, Inc. (Non-Executive Director · Since at least Jul 29, 2021); ALX Oncology Holdings Inc. (Director · Since at least Jul 16, 2020); Jiya Acquisition Corp (Chief Executive Officer, Director · Nov 18, 2020 – Nov 18, 2020 · Past); Aravive Inc (President and CEO, Director · Jan 9, 2020 – Jan 9, 2020 · Past); Arcus Biosciences, Inc. (See Remarks · Mar 25, 2019 – Mar 25, 2019 · Past) | Director · May 1, 2019 – Jun 23, 2020 · Past |
| Dawn Svoronos Other companies: Xenon Pharmaceuticals Inc. (Director · Since at least Sep 27, 2016); Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Global Blood Therapeutics Inc (Director · Dec 19, 2018 – Oct 5, 2022 · Past); Endocyte Inc (Director · May 3, 2018 – Dec 21, 2018 · Past); PTC Therapeutics, Inc. (Director · Jun 10, 2016 – Jun 9, 2022 · Past); Medivation Inc (Director · Apr 22, 2013 – Sep 28, 2016 · Past) | Director · Since at least Dec 9, 2020 |
| Leone Patterson Other companies: Kalaris Therapeutics, Inc. (Director · Since at least Apr 3, 2025); Zymeworks Inc. (EVP, Chief Bus & Fin Officer · Since at least Sep 1, 2024); Nkarta, Inc. (Member of Board of Directors · Since at least Jul 9, 2020); Climb Bio, Inc. (Director · Aug 9, 2021 – May 19, 2022 · Past); Tenaya Therapeutics, Inc. (Chief Fin. and Bus. Officer · Jul 29, 2021 – Feb 23, 2024 · Past); Paratek Pharmaceuticals Inc (Vice President, CFO · Jun 25, 2012 – Oct 30, 2014 · Past) | President and CFO · Jun 15, 2016 – Feb 16, 2021 · Past |
| Linda Bain Other companies: Hemab Therapeutics Holdings, Inc. (Director · Since at least Apr 30, 2026); Autolus Therapeutics plc (Chair of the Audit Committee, Member of the Nominating and Governance Committee · Since at least Mar 18, 2026); Arvinas, Inc. (Director · Since at least Jun 10, 2020); VBI Vaccines Inc. (Director · Jul 1, 2021 – Jan 27, 2022 · Past); Codiak BioSciences Inc (Chief Financial Officer · Oct 13, 2020 – Mar 28, 2023 · Past); Bluebird bio Inc (VP, Fin. & Business Operations · Jun 18, 2013 – Feb 26, 2014 · Past) | Chief Financial Officer · Jul 30, 2014 – Aug 21, 2015 · Past |
| Thomas Woiwode Other companies: Tempest Therapeutics, Inc. (Director · Jun 25, 2021 – Jun 17, 2022 · Past); Aligos Therapeutics, Inc. (Director · Oct 15, 2020 – Jun 23, 2022 · Past); Passage Bio, Inc. (Director · Feb 27, 2020 – May 25, 2023 · Past); Gritstone bio, Inc. (Director · Sep 27, 2018 – Aug 25, 2021 · Past); CRISPR Therapeutics AG (Director · Oct 18, 2016 – Jun 15, 2018 · Past); Audentes Therapeutics Inc (Director · Jul 19, 2016 – Aug 24, 2016 · Past) | Director · May 11, 2016 – May 12, 2021 · Past |
| John Peter McLaughlin Other companies: LENSAR, Inc. (Director · Sep 17, 2020 – May 25, 2023 · Past); Rockwell Medical, Inc. (Director · Sep 5, 2019 – Jun 17, 2021 · Past); PDL BioPharma Inc (Director · Oct 8, 2008 – Dec 21, 2020 · Past); Seagen Inc (Director · Jun 13, 2007 – May 20, 2016 · Past); Anesiva Inc (Chief Executive Officer, Director · May 10, 2006 – Feb 7, 2008 · Past) | Director · Jul 30, 2014 – Feb 12, 2016 · Past |
| Mark Blumenkranz Other companies: Annexon, Inc. (BOARD MEMBER · Since at least Aug 10, 2026); Kala Bio, Inc. (Director · Nov 15, 2021 – Jun 11, 2024 · Past); IVERIC bio Inc (Director · Jul 15, 2020 – Jul 11, 2023 · Past); 1Life Healthcare Inc (Director · Jan 30, 2020 – Feb 22, 2023 · Past); Presbia PLC (Director · Jan 28, 2015 – Mar 16, 2015 · Past) | Director · Jul 30, 2014 – Feb 12, 2016 · Past |
| Mitchell H Finer Other companies: PepGen Inc. (Director · Since at least Mar 27, 2025); Turmeric Acquisition Corp (Director · Oct 15, 2020 – Oct 15, 2020 · Past); Oncorus Inc (Director · Oct 1, 2020 – Jun 23, 2022 · Past); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Feb 13, 2019 · Past); Bluebird bio Inc (Chief Scientific Officer · Jun 18, 2013 – Jun 1, 2015 · Past) | Director · May 11, 2016 – Jul 31, 2019 · Past |
| Laurent Fischer Other companies: AtaiBeckley Inc. (Director · Since at least Jun 4, 2026); Mirum Pharmaceuticals, Inc. (President, Adverum Biotechnologies · Since at least Jul 17, 2019); CTi Biopharma Corp (Director · Jul 21, 2017 – Jun 26, 2023 · Past); Tobira Therapeutics Inc (Chief Executive Officer, Director · May 4, 2015 – Nov 1, 2016 · Past) | CEO, PRESIDENT AND DIRECTOR, Director · Since at least Jun 15, 2020 |
| Linda Rubinstein Other companies: Nektar Therapeutics (Chief Financial Officer · Since at least May 15, 2026); Alector, Inc. (Interim Chief Financial Ofcr · Sep 8, 2021 – Sep 8, 2021 · Past); Five Prime Therapeutics Inc (Interim CFO · Apr 13, 2018 – Apr 13, 2018 · Past); Solexa Inc (VP and CFO · Feb 2, 2006 – Jan 26, 2007 · Past) | CHIEF FINANCIAL OFFICER · Since at least Dec 12, 2022 |
| Paul B Cleveland Other companies: Alder BioPharmaceuticals Inc (Director · Aug 18, 2015 – Oct 22, 2019 · Past); Eiger Biopharmaceuticals Inc (President and CFO · Jun 19, 2014 – Jan 1, 2015 · Past); Sangamo Therapeutics, Inc. (Director · Nov 19, 2008 – Jun 14, 2016 · Past); Affymax Inc (EVP, Corp. Development and CFO · Dec 14, 2006 – Sep 22, 2010 · Past) | Director · Dec 9, 2015 – May 31, 2018 · Past |
| Reed V. Tuckson Other companies: Henry Schein, Inc. (Managing Director of Tuckson Health Connections, LLC; Former Executive Vice President and Chief of Medical Affairs, UnitedHealth Group; and Co-Founder and Board Chairman of the Coalition For Trust in · Since at least May 13, 2021); LifePoint Health Inc (Director · Apr 3, 2014 – Nov 16, 2018 · Past); CTi Biopharma Corp (Director · Sep 22, 2011 – Jun 26, 2023 · Past); UnitedHealth Group Incorporated (EVP & Chief of Medical Affairs · Jan 20, 2011 – Jun 5, 2012 · Past) | Director · Since at least Feb 19, 2021 |
| Eric Carter Other companies: AEON Biopharma, Inc. (Board Member · Since at least Jul 21, 2023); Alder BioPharmaceuticals Inc (Interim Chief Medical Officer · Apr 23, 2018 – Apr 23, 2018 · Past); King Pharmaceuticals Inc (Chief Science Officer · Jan 24, 2007 – Mar 1, 2011 · Past) | Director · Sep 7, 2017 – Jun 23, 2020 · Past |
| James Scopa Other companies: Aligos Therapeutics, Inc. (Director · Since at least Apr 26, 2021); TriVascular Technologies Inc (Director · Apr 15, 2014 – Feb 3, 2016 · Past); Histogen Inc (Director · Jul 24, 2013 – Jun 21, 2018 · Past) | Director · Since at least May 1, 2019 |
| Scott M Whitcup Other companies: Nightstar Therapeutics PLC (Director · Jan 1, 2019 – Jun 7, 2019 · Past); Questcor Pharmaceuticals Inc (Director · Feb 15, 2012 – Aug 14, 2014 · Past); Avanir Pharmaceuticals Inc (Director · Feb 13, 2006 – Feb 14, 2013 · Past) | Director · Since at least Apr 16, 2020 |
| Paul Wachter Other companies: Virgin America Inc (Director · Aug 13, 2015 – Dec 14, 2016 · Past); Time Warner Inc (Director · Oct 28, 2010 – Jun 14, 2018 · Past) | Director · Jul 30, 2014 – Feb 29, 2016 · Past |
| Rabia Gurses Ozden Other companies: Ocular Therapeutix, Inc. (Chief Medical Officer · Jul 1, 2022 – Feb 3, 2024 · Past); Akouos Inc (Chief Development Officer · Jun 25, 2020 – Jun 25, 2020 · Past) | Chief Medical Officer · Since at least Mar 17, 2022 |
| Amber Salzman Other companies: Akcea Therapeutics Inc (Director · Feb 12, 2020 – Oct 12, 2020 · Past) | President and CEO, Director · May 11, 2016 – Feb 15, 2018 · Past |
| Angela Thedinga Other companies: Nkarta, Inc. (Member of Board of Directors · Since at least Mar 28, 2022) | Chief Technology Officer · Feb 21, 2020 – Aug 6, 2021 · Past |
| C. David Nicholson Other companies: Actinium Pharmaceuticals, Inc. (Delaware) (Lead Independent Director · Since at least Mar 17, 2015) | Director · Since at least Nov 3, 2023 |
| Hans Hull Other companies: Pliant Therapeutics, Inc. (Chief Business Officer · Jun 2, 2020 – Jan 23, 2025 · Past) | Chief Executive Officer · Jul 30, 2014 – Aug 21, 2015 · Past |
| Michael Swartzburg Other companies: Iovance Biotherapeutics, Inc. (Vice President, Finance (PAO) · Jun 10, 2020 – Jan 4, 2021 · Past) | Principal Accounting Officer · Nov 30, 2015 – Feb 12, 2016 · Past |
| Nancy E Pecota Other companies: Aradigm Corporation (VP and CFO · Sep 22, 2008 – Dec 6, 2017 · Past) | Principal Accounting Officer · Jun 6, 2022 – Jun 6, 2022 · Past |
| Richard N Spivey Other companies: Rocket Pharmaceuticals, Inc. (Director · Jul 16, 2015 – Jun 20, 2017 · Past) | Director · Apr 19, 2017 – Jul 31, 2019 · Past |
| Samuel B Barone Other companies: Disc Medicine, Inc. (Chief Medical Officer · Apr 12, 2021 – Apr 12, 2021 · Past) | SVP, Clinical Development · Jul 30, 2014 – Feb 9, 2017 · Past |
| Aaron Osborne | Chief Medical Officer · Apr 1, 2019 – Feb 16, 2021 · Past |
| Brigit Riley | Chief Scientific Officer · Sep 2, 2021 – Mar 15, 2023 · Past |
| Carlo Russo | EVP and Chief Medical Officer · May 11, 2016 – May 11, 2016 · Past |
| Christopher DeRespino | See Remarks · Jun 24, 2021 – Jun 24, 2021 · Past |
| Jack Anthony Thrift | Interim CFO · Sep 2, 2021 – Sep 2, 2021 · Past |
| Jennifer C Cheng | General Counsel · Feb 9, 2017 – Feb 14, 2019 · Past |
| John Rakow | SVP, Genl Counsel, Acting CFO · Jun 3, 2022 – Sep 14, 2022 · Past |
| Julie Clark | Chief Medical Officer · Jun 1, 2021 – Sep 30, 2021 · Past |
| Mark L Lupher Jr | Director · Since at least May 1, 2019 |
| Mehdi Gasmi | Director · Jul 30, 2014 – May 12, 2021 · Past |
| Peter Soparkar | CHIEF OPERATING OFFICER · Since at least Oct 30, 2019 |
| Richard Beckman | Chief Medical Officer · Feb 7, 2022 – Mar 1, 2023 · Past |
| Roman G Rubio | SVP, Translational Medicine · Sep 22, 2014 – Feb 12, 2016 · Past |
| Rupert D'Souza | Chief Financial Officer · Dec 6, 2021 – May 13, 2022 · Past |
| Setareh Seyedkazemi | CHIEF DEVELOPMENT OFFICER · Since at least Jan 6, 2022 |
| Shirley Braun | VP, Human Resources · Sep 21, 2015 – Feb 12, 2016 · Past |
| Soo Hong | Director · Since at least Mar 17, 2022 |
| Steven Daniel Schwartz | Director · Jul 30, 2014 – Jun 12, 2017 · Past |
| Szilard Kiss | Director · Since at least Jun 10, 2024 |
| Thomas Leung | Chief Financial Officer · Apr 24, 2019 – Feb 20, 2020 · Past |
| Thomas W Chalberg | Chief Executive Officer, Director · Jul 30, 2014 – Jun 10, 2015 · Past |